{"id":"W4308522396","doi":"10.1016/j.jtocrr.2022.100431","title":"Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Sherbrooke","funders":"Merck Sharp and Dohme; EMD Serono; Astellas Pharma; Chugai Pharmaceutical; Seagen; Mirati Therapeutics; National Cancer Institute; Genomic Health; Genentech; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Celgene; Pfizer","keywords":"Pembrolizumab; Medicine; Internal medicine; KRAS; Oncology; Hazard ratio; Chemotherapy; Confidence interval; Cancer; Immunotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004630454,0.0001771558,0.0007427492,0.0001550486,0.0003611144,0.0000381142,0.00007228113,0.00006950396,0.0002835081],"category_scores_gemma":[0.001077201,0.000118663,0.0001687686,0.0003332235,0.0009498246,0.00007742822,0.00005324414,0.0005295926,4.626884e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001471505,"about_ca_system_score_gemma":0.001941724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003920273,"about_ca_topic_score_gemma":0.00009525313,"domain_scores_codex":[0.9961141,0.0003280036,0.001139381,0.0005532144,0.001469849,0.000395435],"domain_scores_gemma":[0.9948328,0.003425674,0.0004897816,0.0002732067,0.0007144323,0.0002641733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1584321,0.002289125,0.6905137,0.0003618959,0.006893228,0.001577791,0.001974362,0.00009122006,0.0002831131,0.0005465269,0.005527134,0.1315098],"study_design_scores_gemma":[0.04394719,0.01161026,0.9107717,0.00005955703,0.0002142659,0.0006177035,0.001210731,0.0003562197,0.00008333159,0.0007861821,0.03008653,0.0002562689],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897766,0.0004609211,0.0001505348,0.007275486,0.0001853426,0.001658243,0.0001633782,0.00002547465,0.0003040611],"genre_scores_gemma":[0.992723,0.0002677148,0.004355004,0.0005631046,0.0002378429,0.0003046508,0.0002046672,0.00004451741,0.001299523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.220258,"threshold_uncertainty_score":0.4838938,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1407009378247309,"score_gpt":0.4856435322096953,"score_spread":0.3449425943849644,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}